• 1
    Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report: 2006, vol. 18, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta, 2008. Available from: (25 March 2008).
  • 2
    Ruiz MS, Gable AR, Kaplan EH, Stoto MA, Fineberg HV, Trussell J (eds). No Time to Lose: Getting More from HIV Prevention. National Academy Press: Washington, DC, 2001.
  • 3
    Brookmeyer R. Reconstruction and future trends of the AIDS epidemic in the United States. Science 1991; 253:3742.
  • 4
    Rosenberg PS. Scope of the AIDS epidemic in the United States. Science 1995; 270:13721375.
  • 5
    Centers for Disease Control and Prevention. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morbidity and Mortality Weekly Report 1992; 41(RR-17).
  • 6
    Brookmeyer R, Quinn TC. Estimation of current human immunodeficiency virus incidence rates from a cross-sectional survey using early diagnostic tests. American Journal of Epidemiology 1995; 141:166172.
  • 7
    Brookmeyer R, Quinn T, Shepherd M, Mehendale S, Rodrigues J, Bollinger R. The AIDS epidemic in India: a new method for estimating current human immunodeficiency virus (HIV) incidence rates. American Journal of Epidemiology 1995; 142:709713.
  • 8
    Janssen RS, Satten GA, Stramer SL, Rawal BD, O'Brien TR, Weiblen BJ, Hecht FM, Jack N, Cleghorn FR, Kahn JO, Chesney MA, Busch MP. New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. Journal of the American Medical Association 1998; 280:4248.
  • 9
    Parekh BS, McDougal JS. New approaches for detecting recent HIV-1 infection. AIDS Reviews 2001; 3:183193.
  • 10
    Parekh BS, Kennedy MS, Dobbs T, Pau C-P, Byers R, Green T, Hu DJ, Vanichseni S, Young NL, Choopanya K, Mastro TD, McDougal JS. Quantitative detection of increasing HIV type I antibodies after seroconversion: a simple assay for detecting recent HIV infection and estimating incidence. AIDS Research and Human Retroviruses 2002; 18:295307.
  • 11
    Satten GA, Janssen R, Busch MP, Datta S. Validating marker-based incidence estimates in repeatedly screened populations. Biometrics 1999; 55:12241227.
  • 12
    Kaplan EH, Brookmeyer R. Snapshot estimators of recent HIV incidence rates. Operations Research 1999; 47:2937.
  • 13
    Lee LM, McKenna MT. Monitoring the incidence of HIV infection in the United States. Public Health Reports 2007; 122(Supplement 1):7279.
  • 14
    Green TA. Using surveillance data to monitor trends in the AIDS epidemic. Statistics in Medicine 1998; 17:143154.
  • 15
    Song R, Hall HI, Frey R. Uncertainties associated with incidence estimates of HIV/AIDS diagnoses adjusted for reporting delay and risk redistribution. Statistics in Medicine 2005; 24:453464.
  • 16
    Longini Jr IM, Clark WS, Byers RH, Ward JW, Darrow WW, Lemp GF, Hethcote HW. Statistical analysis of the stages of HIV infection using a Markov model. Statistics in Medicine 1989; 8:831843.
  • 17
    Longini Jr IM, Clark WS, Gardner LI, Brundage JF. The dynamics of CD4+ T-lymphocyte decline in HIV-infected individuals: a Markov modeling approach. Journal of Acquired Immune Deficiency Syndromes 1991; 4:11411147.
  • 18
    Johnson NL, Kotz S. Distributions in Statistics: Continuous Univariate Distributions, vol. 1. Wiley: New York, 1970.
  • 19
    Rubin DB. Multiple imputation after 18+ years. Journal of the American Statistical Association 1996; 91:473489.
  • 20
    Song R, Karon JM, White E, Goldbaum G. Estimating the distribution of a renewal process from times at which events from an independent process are detected. Biometrics 2006; 62:838846.
  • 21
    Hall HI, Song R, Rhodes P, Prejean JG, An Q, Lee LM, Karon J, Brookmeyer R, Kaplan EH, McKenna MT, Janssen RS, the HIV Incidence Surveillance Group. Estimation of HIV incidence in the United States, 2005; submitted for publication.
  • 22
    Quan VM, Steketee RW, Valleroy L, Weinstock H, Karon J, Janssen R. HIV incidence in the United States, 1978–1999. Journal of Acquired Immune Deficiency Syndromes 2002; 31:188201.
  • 23
    Zapka JG, Bigelow C, Hurley T, Ford LD, Egelhofer J, Cloud WM, Sachsse E. Mammography use among sociodemographically diverse women: the accuracy of self-report. American Journal of Public Health 1996; 86:10161021.
  • 24
    Hall HI, Van Den Eeden SK, Tolsma DD, Rardin K, Thompson T, Sinclair AH, Madlon-Kay DJ, Nadel M. Testing for prostate and colorectal cancer: comparison of self-report and medical record audit. Preventive Medicine 2004; 39:2735.
  • 25
    Johnson EO, Schultz L. Forward telescoping bias in reported age of onset: an example from cigarette smoking. International Journal of Methods in Psychiatric Research 2005; 14:119129.
  • 26
    Collaborative Group on AIDS Incubation and HIV Survival Including the CASCADE EU Concerted Action. Time from HIV-1 seroconversion to AIDS and death before widespread use of high-active antiretroviral therapy: a collaborative re-analysis. Lancet 2000; 355:11311137.
  • 27
    McDougal JS, Parkh BS, Peterson ML, Branson BM, Dobbs T, Ackers M, Gurwith M. Comparison of HIV type 1 incidence observed during longitudinal follow-up with incidence estimated by cross-sectional analysis using the BED capture enzyme immunoassay. AIDS Research and Human Retroviruses 2006; 22:945952.
  • 28
    Hall HI, Song R, Gerstle III JE, Lee LM, on behalf of the HIV/AIDS Reporting System Evaluation Group. Assessing the completeness of reporting of human immunodeficiency virus diagnoses in 2002–2003: capture–recapture methods. American Journal of Epidemiology 2006; 164:391397.
  • 29
    Suligoi B, Galli C, Mass M, Si Sora F, Sciandra M, Pezzotti P, Recchia O, Montella F, Sinicco A, Rezza G. Precision and accuracy of a procedure for detecting recent human immunodeficiency virus infections by calculating the antibody avidity index by an automated immunoassay-based method. Journal of Clinical Microbiology 2002; 40:40154020.
  • 30
    Barin F, Meyer L, Lancar R, Deveau C, Charib M, Laporte A, Dsenclos J-C, Costagliola D. Development and validation of an immunoassay for identification of recent human immunodeficiency virus type 1 infections and its use on dried serum spots. Journal of Clinical Microbiology 2005; 43:44414447.